Mucosal injury from targeted anti-cancer therapy
β Scribed by Dorothy M. K. Keefe; Rachel J. Gibson
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 177 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dr. Sonis has served as a consultant for Biomodels and Affiliates, LLC (Wellesley, MA). Dr. Elting has received speaker's honoraria from McNeill Pharmaceuticals and Endo Pharmaceuticals (Chadds Ford, PA). Dr. Keefe has received research funding and speaker's honoraria from Amgen. Dr. Peterson has se
## Abstract Tumor angiogenesis is believed to result from an imbalance of proβ and antiβangiogenic factors, some of which are candidates for targeted therapy. Such therapy has raised hopes for patients with undifferentiated thyroid carcinomas, who are facing a grave prognosis with a survival of onl